IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue992,075882,734796,717
Cost of Revenue349,089326,542302,946
Gross Profit642,986556,192493,771
Operating Expenses
Research Development58,15550,89543,559
Selling General and Administrative455,629415,757375,545
Non Recurring---
Others13,8629,9536,810
Total Operating Expenses---
Operating Income or Loss115,34079,58767,857
Income from Continuing Operations
Total Other Income/Expenses Net8694,618-324
Earnings Before Interest and Taxes116,20984,20567,533
Interest Expense25,80323,53421,967
Income Before Tax90,40660,67145,566
Income Tax Expense15,84253,8209,271
Minority Interest---
Net Income From Continuing Ops74,5646,85136,295
Non-recurring Events
Discontinued Operations--10,370-2,291
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income74,564-3,51934,004
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares74,564-3,51934,004